Lexie B2 Plus vs RCA In-Ear

The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5 in HearAdvisor's lab testing, ranking #7 among 65 OTC devices. Priced at $899, this behind-the-ear rechargeable device has earned back-to-back Expert's Choice Awards in 2023 and 2024. In our testing, the B2 Plus demonstrates strong speech-in-quiet performance at 4.3/5, which is 1.49 points above the OTC category average. Own-voice comfort is excellent at 4.8/5, measuring 2.29 points above average—a notable strength that may appeal to users who find their own voice bothersome with other devices. Speech-in-noise scores 2.1/5, which is above the category average by 0.58 points but remains mixed in absolute terms, reflecting the broader challenge OTC devices face in noisy environments. The device does show a weakness in feedback handling, scoring 2.8/5—which is 1.74 points below the category average of 4.54/5. Users may encounter occasional whistling during activities that bring objects close to the ear. Music streaming performance is mixed at 2.6/5, though still 0.68 points above the OTC average. The Lexie B2 Plus offers both iPhone and Android streaming compatibility. It's well-suited for users prioritizing clear speech in quieter settings and natural own-voice perception, though those frequently in noisy environments or concerned about feedback stability may want to consider alternatives like the Sony CRE-E10 in this price range.

The RCA In-Ear is a budget-priced OTC hearing aid available for $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC hearing aid category, ranking 64th out of 65 devices tested. In our standardized testing, the RCA In-Ear shows a mixed performance profile. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal wear. Own-voice comfort scores 2.6/5, which is essentially at the category average (+0.09 points), offering mixed but acceptable performance for how your own voice sounds while wearing the devices. However, the core speech performance metrics present significant limitations. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, and speech in noise also scores 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio entertainment purposes. At this price point, buyers have considerably stronger options. Competitors like the Lucid Enrich Pro and JLab Hear OTC offer better sound performance at lower prices. The RCA In-Ear may appeal to those prioritizing feedback-free wear above speech clarity, but most users seeking meaningful hearing benefit should consider higher-performing alternatives in this budget segment.